The findings revealed that the mRNA expression of COL4A4 was stably increased in low T and M stage groups as well as in the low WHO grade group (Figure 4E–G), and these results were further validated in the test cohort (Figure S1A–C), implying that COL4A4 might act as an important predictive factor in tumor development. Here, COL4A4 is linked to neoplasm.